← Back
$AIDX All transactions

20/20 Biolabs, Inc.

C

$ Value

$0

Shares

13,029

Price

$0

Filed

Feb 23

Insider

Name

Rollins John Woodson

Title

CIK

0002112941

Roles

Director

Transaction Details

Transaction Date

2026-02-19

Code

C

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

24,140

Footnotes

On February 19, 2026, all shares of series A preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A preferred stock had no expiration date. | On February 19, 2026, all shares of series A-2 preferred stock held by the Reporting Person were automatically converted into an equivalent number of shares of common stock upon the listing of the Issuer's common stock on the Nasdaq Capital Market. The series A-2 preferred stock had no expiration date.

Filing Info

Accession No.

0001213900-26-019456

Form Type

4

Issuer CIK

0001139685

Rollins John Woodson's History

Date Ticker Type Value
2026-02-19 AIDX C $0
2026-02-19 AIDX C $0
2026-02-19 AIDX C
2026-02-19 AIDX C

Other Insiders at AIDX (90d)

Insider Bought Sold Last
COHEN RICHARD M 2026-02-19
Bergman Alan B.
Chief Financial Officer
2026-04-02
Compton John G. 2026-02-19
Ross Michael A. 2026-02-19
Zhou Jiming
Chief Operating Officer
2026-04-02
Cohen Jonathan M
Chief Executive Officer
2026-03-03
Rollins John Woodson 2026-02-19